A study-by-study reading of the sermorelin record.

What this is

Order Sermorelin reads the peer-reviewed literature on sermorelin — the GHRH(1-29) growth-hormone secretagogue — and sets it out study by study, in plain terms. It is not a clinic and keeps no clinical staff; it gives no diagnosis, no dose guidance, and no medical advice; it makes and supplies nothing. What you are reading is an account of published science, composed dot by dot from the record itself.

How it is made

The pages are built on the primary literature: the pediatric growth-hormone-deficiency trial, the older-men GH/IGF-1 studies, the pharmacokinetic work, the GHRH-analog cognition trial, the men's-health secretagogue research, and the editorials that set the adult anti-aging caution. Each quantity here is tied to a numbered study on the references page, and any finding that belongs to a related analog — tesamorelin, CJC-1295, ipamorelin — is labeled as such rather than folded into "sermorelin."

The reading favors precision over enthusiasm. Where the evidence is strong, it says so plainly; where the marketing has outrun the studies, it marks the gap rather than smoothing it over.

What the name means

The word "order" in the name is a reading term, not a transaction. It points to the order of a composed reading — the careful arrangement of a stippled plate, the ordered record of a literature worked through study by study. It marks the stance this publisher takes toward the science, not a service on offer. No order is taken here, no prescription filled, no supplier introduced; nothing is dosed, dispensed, or sold.

Where a compound carries a documented regulatory history, that history is stated plainly: sermorelin was an FDA-approved drug for pediatric growth hormone deficiency, withdrawn from the US market in 2008 for commercial reasons, and is now prepared by compounding pharmacies. The record is reported as record — not as an invitation to obtain the substance.

What we do not do

No human dose is recommended here, no condition diagnosed, no treatment suggested. There is no clinic, no pharmacy, no physical address, and no clinical team; no founding physician or named expert stands behind the byline — the work is a reading of the literature, presented as one. If you are weighing anything described here against a personal decision, that belongs with a qualified clinician who has access to your history, not with a set of pages that only read the studies.